Ironwood Pharmaceuticals | IRWD - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Almirall EUR 1.49B 24.03M 2025-12
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amarin USD 449.41M 9.87M 2026-03
Ardelyx USD 148.62M 18.33M 2026-03
Astellas Pharma JPY 1.83T 65.92B 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Charles River Laboratories USD 2.9B 265.94M 2026-03
Coherus Biosciences USD 61.01M 26.76M 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -307.93M 5.97M 2026-03
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Incyte USD 5.62B 455.37M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
MacroGenics USD 21.2M 34.39M 2026-03
Moderna USD 7.41B 1.24B 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Pacira USD 653.89M 39.22M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Takeda JPY 7.77T 129.5B 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12